Page 38 - CIRN Annual Report 2017

(iCARE) Network. Population immunity to measles and varicella in Ontario Abstract
S Bolotin, A Severini. TF Hatchette, E McLachlan, H Scholz, S Deeks, S Wilson, M
Brisson, S Halperin, J Gubbay, T Mazzulli, B Serhir, B Ward, I Gemmill, S Squires,
Calibration and evaluation of quantitative antibody titers for varicella-zoster virus
NS Crowcroft, on behalf of the Immunity of Canadians and Risk of Epidemics
E McLachlan, TF Hatchette, H Scholz, S Bolotin, NS Crowcroft, A Severini.

using the BioPlex 2000. Abstract for CIRN 2017 AGM. (accepted)

for CIRN 2017 AGM. (accepted) RR Higgins, E Lombos, E McLachlan, S Bolotin, A Severini, N Crowcroft, JB Gubbay and T Mazzulli. Evaluation of a laboratory-developed multiplex measles, mumps, rubella and varicella (MMRV) microsphere immunoassay for detection of varicella zoster virus igg antibodies in human serum by comparison to two commercial assays. CIRN AGM 2017 accepted for poster presentation. FM Guerra, NS Crowcroft, SL Deeks, SA Halperin, A Seve

Bolotin. Waning of measles maternal antibody in infants – A systematic literature
ce
FM Guerra, NS Crowcroft, SL Deeks, SA Halperin, A Severini, TF Hatchette, S
review focusing on measles elimination settings Canadian Immunization

Conference, Ottawa ON. Dec 6, 2016. (Poster) NL Gilbert, J Rotondo, J Shapiro,L Sherrard, WD Fraser, BJ Ward. Seroprevalence and determinants of rubella antibodies in Canadian pregnant women, 2008-2011. Vaccine 2017 (in press) TF Hatchette, H Scholz, S Bolotin, NS Crowcroft, C Jackson, McLachlan, A Severini, on behalf of the Immunity of Canadians and Risk of Epidemics (iCARE) laboratory group and the Canadian Immunization Research Network (CIRN). Determinati